Hyperlipidemia - Side-effect of the treatment with an atypical antipsychotic (zotepine)?;Hyperlipidämie - Nebenwirkung bei behandlung mit einem atypischen neuroleptikum (zotepin)?

Psychiatrische Praxis

Volumn 29, Issue 8, 2002, Pages 438-440

  Wetterling, Tilman ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BIPERIDEN; ZOTEPINE;

ARTICLE; DRUG BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; METABOLIC DISORDER; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIEPINS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; LIPIDS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TRIGLYCERIDES; WEIGHT GAIN;

EID: 0036864109     PISSN: 03034259     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35507     Document Type: Article

References (11)

1. Kato MM, Goodnick PJ. Antipsychotic medication: Effects on regulation of glucose and lipids. Expert Opin Pharmacother 2001; 2: 1571-1582
2. Henderson DC, Cagliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA, Goff DC. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. Am J Psychiatry 2000; 157: 975-981
3. McIntyre RS, McCann SM, Kennedy SH. Antipsychotic metabolic effects: Weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry 2001; 46: 273-281
4. Mir S, Taylor D. Atypical antipsychotics and hyperglycaemia. Int Clin Psychopharmacol 2001; 16: 63-73
5. Austin MA. Epidemiology of hypertriglyceridemia and cardiovascular disease. Am J Cardiol 1999; 83: 13F-16F
6. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 2000; 86: 943-949
7. Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol 1980; 46: 649-654
8. Hauner H. Verbreitung des diabetes mellitus in Deutschland. DMW 1998; 123: 777-782
9. Rehm J, Sempos C, Kohlmeier L, Myers G, Thefeld W, Gunter E, Thamm M, Dortschy R, Murphy R, Feinleib M, Hoffmeister H. A comparison of serum total cholesterol levels and their determinants between the Federal Republic of Germany and the United States. Eur J Epidemiol 2000; 16: 669-675
10. Wetterling T. Gewichtszunahme - Eine unterschätzte nebenwirkung von atypischen neuroleptika? Fortschr Neurol Psychiat 2000; 68: 546-556
11. Wetterling T, Müßigbrodt H. Gewichtszunahme - Eine nebenwirkung von nipolept (zotepin)? Nervenarzt 1996; 67: 256-261